Fasenra pen 30 MG/mlml
Ended Awarded Last action
- Contract number
- SPE2DR26FJUY3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,963
Award facts
- Contract value 100% obligated
- $14,962.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,962.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Fasenra Pen 30 mg/ml. The delivery order, issued on January 26, 2026, with an ultimate completion date of January 27, 2026, carries no set-aside designation, indicating the vendor competed in the open market. DMS Pharmaceutical Group is the sole awardee with no identified subcontractors on this order.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy designed to supply pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. The parent contract, valued at $499.9 million with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as one of multiple regional prime vendor contractors authorized to fulfill recurring pharmaceutical supply needs across the military medical system. This specific delivery order for Fasenra, a specialty pharmaceutical treatment, exemplifies the vendor's established capability to supply specialized biologics as part of its comprehensive pharmaceutical product portfolio supporting federal military medical operations.
Quick answers
Who was awarded contract SPE2DR26FJUY3?
SPE2DR26FJUY3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FJUY3 worth?
The government has obligated $14,963 on SPE2DR26FJUY3.
Is contract SPE2DR26FJUY3 an order under another contract?
Yes. SPE2DR26FJUY3 is a delivery order under SPE2DR25D9329, an indefinite delivery contract.
Was contract SPE2DR26FJUY3 competed?
The extent of competition for SPE2DR26FJUY3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award